FDA has issued an emergency use authorization (EUA) for Alton Diagnostics GmbH’s RealStar MERS-CoV RT-PCR Kit, used to detect Middle East Respiratory Syndrome CoronaVirus, or MERS-CoV.
FDA issued the authorization on the condition that the firm make fact sheets available to health care providers the describe interpreting results from the test; and to patients on understanding...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?